Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis
Bo Yang, Qian Ren, Ji‐chun Zhang, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 5, pp. e1128-e1128
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
Kenji Hashimoto
Biochemical Pharmacology (2020) Vol. 177, pp. 113935-113935
Open Access | Times Cited: 188
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei Yan, Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 559-573
Open Access | Times Cited: 180
A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration
Jiancheng Zhang, Li Ma, Lijia Chang, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 168
Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 93
Brain-spleen axis in health and diseases: A review and future perspective
Wei Yan, Tong Wang, Lei Liao, et al.
Brain Research Bulletin (2022) Vol. 182, pp. 130-140
Open Access | Times Cited: 87
The role of brain derived neurotrophic factor in central nervous system
Yiyi Li, Fang Li, Dongdong Qin, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 77
BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions
Ana Salomé Correia, Armando Cardoso, Nuno Vale
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2081-2081
Open Access | Times Cited: 48
Towards an understanding of the physical activity-BDNF-cognition triumvirate: A review of associations and dosage
Erin Walsh, Lisa M. Smith, Joe Northey, et al.
Ageing Research Reviews (2020) Vol. 60, pp. 101044-101044
Open Access | Times Cited: 120
Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective
Kenji Hashimoto
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 91
Impact of brain‐derived neurotrophic factor genetic polymorphism on cognition: A systematic review
Yi Long Toh, Terence Ng, Megan Tan, et al.
Brain and Behavior (2018) Vol. 8, Iss. 7
Open Access | Times Cited: 88
Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem
Н. К. Попова, В. С. Науменко
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 3, pp. 227-239
Closed Access | Times Cited: 84
Chronic Stress Weakens Connectivity in the Prefrontal Cortex: Architectural and Molecular Changes
Elizabeth Woo, Lauren Sansing, Amy F.T. Arnsten, et al.
Chronic Stress (2021) Vol. 5
Open Access | Times Cited: 81
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents
Wei Yao, Song Lin, Jin Su, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 79
BDNF and pro-BDNF in serum and exosomes in major depression: Evolution after antidepressant treatment
Thibaut Gellé, Rayhanatou Altine Samey, Brigitte Plansont, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 109, pp. 110229-110229
Open Access | Times Cited: 77
The kynurenine pathway in major depression: What we know and where to next
Samara Brown, Xu‐Feng Huang, Kelly A. Newell
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 917-927
Closed Access | Times Cited: 67
MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets
Heng-Chang Zhang, Yang Du, Lei Chen, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105064-105064
Closed Access | Times Cited: 33
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review
Mario Ignacio Zelada, Verónica Garrido, Andrés Liberona, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14810-14810
Open Access | Times Cited: 26
Current progression in application of extracellular vesicles in central nervous system diseases
Xiangmin Zhang, Jie Huang, Xiaoying Ni, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 9
Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances
Ana Salomé Correia, Nuno Vale
International Journal of Translational Medicine (2024) Vol. 4, Iss. 1, pp. 176-196
Open Access | Times Cited: 8
Focused ultrasound-induced blood-brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model
Jaewoo Shin, Chanho Kong, Jihyeon Lee, et al.
Alzheimer s Research & Therapy (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 75
Oxidative stress inhibition by resveratrol in alcohol-dependent mice
Carla Petrella, Valentina Carito, Claudio Carere, et al.
Nutrition (2020) Vol. 79-80, pp. 110783-110783
Open Access | Times Cited: 56
Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases
Mingyue Wang, Yuhuan Xie, Dongdong Qin
Brain Research Bulletin (2020) Vol. 166, pp. 172-184
Closed Access | Times Cited: 52
New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism
Carlye Szarowicz, Kathy Steece‐Collier, Margaret E. Caulfield
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 8011-8011
Open Access | Times Cited: 34
The Role of Brain-Derived Neurotrophic Factor in Immune-Related Diseases: A Narrative Review
Marcin Sochal, Marta Ditmer, Agata Gabryelska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 6023-6023
Open Access | Times Cited: 34
Nrf2 regulates the arginase 1+ microglia phenotype through the initiation of TREM2 transcription, ameliorating depression-like behavior in mice
Lujuan He, Yi Zheng, Lixuan Huang, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top